AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $36.26
- 52-wk high
- $37.83
- High
- $36.81
- 52-wk low
- $17.82
- Low
- $36.09
- Prev close
- $36.52
Smart money
Earnings
Earnings came in $0.59 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.48B | $4.71B | $3.98B | $4.14B |
| Cost of what it sold | $2.18B | $2.06B | $2.01B | $1.99B |
| Gross profit | $2.30B | $2.66B | $1.97B | $2.15B |
| What it spent | ||||
| Research and development | $256.0M | $267.0M | $222.0M | $250.0M |
| Sales and admin | $317.0M | $367.0M | $304.0M | $317.0M |
| Other operating costs | $849.0M | $1.72B | $792.0M | $1.44B |
| Total operating expenses | $1.42B | $2.35B | $1.32B | $2.00B |
| What was left | ||||
| Operating profit | $882.0M | $300.0M | $652.0M | $149.0M |
| Interest on debt | $209.0M | $292.0M | $201.0M | $200.0M |
| Profit before tax | $648.0M | $91.0M | $436.0M | -$455.0M |
| Tax | $214.0M | -$390.0M | $67.0M | $121.0M |
| Net profit | $433.0M | $480.0M | $369.0M | -$576.0M |
| EBITDA | $1.10B | $632.0M | $877.0M | -$19.0M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
85overbought
20D volatility
43%annualized
52-week range
$17.82$37.83
20D support
News
What the news says
31 articles · 7 days
Coverage is bullish
Tone of tracked coverage
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing (Aug 17, 2026)
NeutralAug 17Teva Pharmaceutical’s stock is near its yearly high; is it still a buy?
NeutralAug 17Empowered Funds LLC Increases Stake in Teva Pharmaceutical Industries Ltd. $TEVA
NeutralAug 17